Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

16 treatments under study, led by Flexible Sigmoidoscopy With Colonic Biopsies

Research Leaders

20 sponsors active, led by Naval Medical Research Center

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total
Phase 1 (2)
Phase 2 (1)
Phase 2/3 (1)

Trial Status

Unknown5
Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04182490Phase 2CompletedPrimary

LMN-101 in a Campylobacter Human Challenge Model

NCT06432777UnknownPrimary

Recurrent Campylobacter Bacteraemia in Immunocompromised Patients

NCT06425250UnknownPrimary

Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study

NCT03683667Phase 2/3Completed

Protein Plus: Improving Infant Growth Through Diet and Enteric Health

NCT03266068CompletedPrimary

Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders

NCT02040922UnknownPrimary

Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota

NCT02884752CompletedPrimary

Retrospective Study of Bone Infection Due to Campylobacter Spp

NCT01048112Phase 1UnknownPrimary

Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection

NCT00434798Phase 1UnknownPrimary

Campylobacter Jejuni Challenge Model Development: Dose Ranging Study

Showing all 9 trials

Research Network

Common Treatments

  • Flexible Sigmoidoscopy With Colonic Biopsies1
  • Characteristics Of Patients And Campylobacter Bacteraemia Episodes1
  • Description Of The Evolution And Risk Factors For Failure Of Osteoarticular Infections Caused By Campylobacter Spp1
  • Management Progression And Risk Factors For Failure Of Bji Caused By Campylobacter Spp1
  • Nutrition Education1

Active Sponsors

  • Naval Medical Research Center3
  • University of Vermont2
  • Hospices Civils de Lyon2
  • University of Nottingham1
  • Centre de Référence des Infections Ostéo-Articulaires du Grand Ouest1

Top Investigators

Related Conditions

  • Irritable Bowel Syndrome2
  • Enteric Pathogens1
  • Stunting1
  • Malnutrition Protein1
  • Bone Diseases Infectious1

Activity Timeline